| 288.5 | J07AG01 | hemofilus influenze B, čistěný purifikovaný antigen | parent. | 1 | DF | 212,30 | O/P |
| 288.6 | J07AG51 | hemofilus influenze B, kombinace s toxoidy | parent. | 1 | DF | 212,30 | O/P |
| 288.7 | J07AL01 | pneumokoková vakcína | parent. | 1 | DF | 208,70 | O/P |
| 288.8 | J07AM51 | tetanový anatoxin, kombinace s anatoxinem záškrtu | parent. | 1 | DF | 11,67 | O/P |
| 01221 | ALDITEANA SEVAC | inj 10x0.5ml | SEV | CZ |
| 288.9 | J07BB02 | chřipka, čištěný antigen | parent. | 1 | DF | 188,90 | O/P |
| 12877 | INFLUVAC | injsus10x0.5ml/1dáv | SOO | NL |
| 83429 | VAXIGRIP | inj 1x0.5ml | PMX | F |
| 49482 | INFLUVAC | injsus1x0.5ml/dav. | SOO | NL |
| 288.10 | J07BF03 | dětská obrna, trivalentní, inaktivovaný celý virus | parent. | 1 | DF | 95,30 | O/P |
| 288.11 | J07BJ01 | zarděnky, živý oslabený virus | parent. | 1 | DF | 74,00 | O/P |
| 88548 | ERVEVAX RUBELLA VACCINE S.C. | inj sic 10dav.+solv | SKX | B |
| 88549 | ERVEVAX RUBELLA VACCINE | inj pso Iqf 50dÁv. | SKX | B |
| 288.12 | J07AH03 | meningokokus, bivalentni čištěný polysacharidový antigen | parent. | 1 | DF | 115,10 | O/P |
| 76063 | MENINGOCOCCAL POLYS.A+C VACCINE | inj 1x1dav.+strik. | PMX | F |
| 289 | J07BG | očkovací látky proti vzteklině | parent. |
|---|
| 289.1 | J07BG01 | inaktivovaný celý virus vztekliny | parent. | plně | K |
| 93706 | VERORAB | inj sic 1dav.+0.5ml | PMX | F |
| 90996 | RABIPUR | inj sic 5x2.5ut | CBG | D |
| 75379 | RABIPUR | inj sic 1x2.5ut | CBG | D |
| 290 | L01AA | alkylační cytostatika | p.o. |
|---|
| 290.1 | L01AA01 | cyklofosfamid | p.o. | 0.1 | GM | 5,44 |
| 94174 | CYCLOPHOSPHAMIDE ORION | tbl obd 50x50mg | ONA | SF |
| 290.2 | L01AA02 | chlorambucil (do 2 mg v jedné tabletě včetně) | p.o. | 1 | MG | 4,50 |
| 11244 | LEUKERAN | tbl obd 25x2mg | GWE | GB |
| 290.3 | L01AA02 | chlorambucil (nad 2 mg v jedné tabletě) | p.o. | 1 | MG | 3,72 | |
| 290.4 | L01AA03 | melfalan (do 2 mg v jedné tabletě včetně) | p.o. | 1 | MG | 4,30 | |
| 32213 | ALKERAN 2 MG | por tbl obd 25x2mg | GOK | GB |
| 290.5 | L01AA03 | melfalan (nad 2 mg v jedné tabletě) | p.o. | 1 | MG | 2,88 | |
| 290.6 | L01AA08 | prednimustin | p.o. | 1 | MG | 3,62 | |
| 290.7 | L01AX03 | temozolomid | p. o. | 370 | MG | 15992,78 | X |
| 66104 | TEMODAL 100MG | cps 5x100mg | SCH | B |
| 66109 | TEMODAL 20MG | cps 5x20mg | SCH | B |
| 66106 | TEMODAL 250MG | cps 5x250mg | SCH | B |
| 291 | L01AA | alkylační cytostatika | parent. |
|---|
| 291.1 | L01AA01 | cyklofosfamid | parent. | 10 | MG | 3,52 | B |
| 10777 | CYTOXAN 1 G | inj sic 6x1gm | BMS | POR |
| 10776 | CYTOXAN 500 MG | inj sic 12x500mg | BMS | POR |
| 291.2 | L01AA03 | melfalan | parent. | 1 | MG | 12,61 | B/ONK,HEM |
| 32508 | ALKERAN | inj pso Iqf 50mg | GOK | GB |
| 32507 | ALKERAN | inj pso lqf 50mg | GXW | I |
| 291.3 | L01AA05 | chlormethin | parent. | 1 | MG | 34,22 | B/ONK,HEM |
| 291.4 | L01AA06 | ifosfamid (do 500 mg v jedné ampuli včetně) | parent. | 1 | MG | 1,42 | B/ONK,HEM |
| 291.5 | L01AA06 | ifosfamid (nad 500 mg v jedné ampuli) | parent. | 1 | MG | 1,32 | B/ONK,HEM |
| 32275 | HOLOXAN 2 G | inj sic 1x2gm | HOD | D |
| 70469 | HOLOXAN 2GM | inj sic 1x2gm | ASD | D |
| 291.6 | L01AC01 | thiotepa | parent. | 1 | MG | 21,31 | B/ONK,HEM |
| 291.7 | L01AX04 | dakarbazin | parent. | 10 | MG | 7.90 | B/ONK,HEM |
| 89999 | DACARBAZIN LACHEMA 1000 | inj sic 1x1000mg | LCM | CZ |
| 88560 | DACARBAZIN LACHEMA 500 | inj sic 1x500mg | LCM | CZ |
| 88441 | DACARBAZIN LACHEMA 200 | inj sic 10x200mg | LCM | CZ |
| 88561 | DACARBAZIN LACHEMA 500 | inj sic 5x500mg | LCM | CZ |
| 88440 | DACARBAZIN LACHEMA 100 | inj sic 10x100mg | LCM | CZ |
| 90000 | DACARBAZIN LACHEMA 1000 | inj sic 5x1000mg | LCM | CZ |
| 292 | L01AB | alkylsulfaty p.o. |
|---|
| 292.1 | L01AB01 | busulfán (do 0,5 mg v jedné tabletě včetně) | p.o. | 1 | MG | 14,86 | L/ONK,HEM |
| 292.2 | L01AB01 | busulfán (nad 0,5 mg v jedné tabletě) | p.o. | 1 MG | 4,89 | L/ONK,HEM | |
| 293 | L01AD | nitrosomočoviny | p.o. |
|---|
| 293.1 | L01AD02 | lomustin (do 10 mg v jedné tabletě včetně) | p.o. | 1 | MG | 5,72 | L/ONK,HEM |
| 293.2 | L01AD02 | lomustin (nad 10 do 40 mg v jedné tabletě včetně) | p.o. | 1 | MG | 5,63 | L/ONK,HEM |
| 293.3 | L01AD02 | lomustin (nad 40 mg v jedné tabletě) | p.o. | 1 | MG | 4,39 | L/ONK,HEM |
| 294 | L01AD | nitrosomočoviny | parent. |
|---|
| 294.1 | L01AD01 | karmustin | parent. | 1 | MG | 9,92 | B/ONK,HEM |
| 53666 | BICNU(STERILE CARMUSTINE/BCNU/) | inj sic 1x100mg+sol | BMS | I |
| 294.2 | L01AD04 | streptozocin | parent. | 10 | MG | 14,81 | B/ONK,HEM |
| 294.3 | L01AD05 | fotemustin | parent. | 1 | MG | 94,48 | X |
| 295 | L01BA | antimetabolity ze skupiny analog kyseliny listové | p.o. |
|---|
| 295.1 | L01BA01 | metotrexát | p.o. | 1 | MG | 1,52 |
| 91922 | METHOTREXAT LACHEMA 10 | tbl 100x10mg | LCM | CZ |
| 91065 | METHOTREXAT LACHEMA 2.5 | tbl 100x2.5mg | LCM | CZ |
| 296 | L01BA | antimetabolity ze skupiny analog kyseliny listové | parent. |
|---|
| 296.1 | L01BA01 | metotrexát (do 5 mg v jedné ampuli včetně) | parent. | 1 | MG | 9,09 | B |
| 91025 | METHOTREXAT LACHEMA 5 | inj 10x2ml/5mg | LCM | CZ |
| 10827 | METHOTREXATE-TEVA 2.5MG/ML | inj 5x2ml/5mg | PHM | NL |
| 296.2 | L01BA01 | metotrexát (nad 5 do 500 mg v jedné ampuli včetně) | parent. | 1 | MG | 3,23 | B |
| 87564 | METHOTREXAT LACHEMA 50 | inj sic 10x50mg | LCM | CZ |
| 64784 | METHOTREXAT EBEWE | inf 1x5ml/500mg | EBW | A |
| 87761 | METHOTREXAT LACHEMA 500 | inj sic 10x500mg | LCM | CZ |
| 11195 | METHOTREXATE-TEVA 25MG/ML | inj 1x20ml/500mg-la | PHM | NL |
| 11194 | METHOTREXATE-TEVA 25MG/ML | inj 1x8ml/200mg-lah | PHM | NL |
| 93963 | METHOTREXAT LACHEMA 20 | inj 10x2ml/20mg | LCM | CZ |
| 93964 | METHOTREXAT LACHEMA 50 | inj 10x5ml/50mg | LCM | CZ |
| 11191 | METHOTREXATE-TEVA 25MG/ML | inj 1x2ml/50mg-lahv | PHM | NL |
| 11193 | METHOTREXATE-TEVA 25MG/ML | inj 1x4ml/100mg-lah | PHM | NL |
| 11192 | METHOTREXATE-TEVA 25MG/ML | inj 5x2ml/50mg-amp. | PHM | NL |
| 296.3 | L01BA01 | metotrexát (nad 500 mg v jedné ampuli) | parent. | 10 | MG | 4,89 | B |
| 93965 | METHOTREXAT LACHEMA 1000 | inj 10x20ml/1000mg | LCM | CZ |
| 296.4 | L01BA03 | raltitrexed | parent. | 1 | DF | 7498,20 | X |
| 65351 | TOMUDEX | inj sic 1x2mg | AZC | GB |
| 297 | L01BB | antimetabolity ze skupiny analog purinů | p.o. |
|---|
| 297.1 | L01BB02 | merkaptopurin | p.o. | 10 | MG | 6,21 | L/ONK,HEM |
| 94241 | PURI-NETHOL | tbl 25x50mg | BWE | GB |
| 297.2 | L01BB03 | tioguanin | p.o. | 10 | MG | 9.34 | L/ONK,HEM |
| 297.3 | L01BB05 | fludarabin | p.o. | 1 | MG | 87,20 | L/ONK,HEM |
| 58898 | FLUDARA | tbl obd 20x10mg | SAG | D |
| 58897 | FLUDARA | tbl obd 15x10mg | SAG | D |
| 298 | L01BB | antimetabolity ze skupiny analog purinů | parent. |
|---|
| 298.1 | L01BB04 | cladribin | parent. | 1 | MG | 884,61 | B/ONK,HEM |
| 298.2 | L01BB05 | fludarabin | parent. | 1 | MG | 126,51 | B/ONK,HEM |
| 77008 | FLUDARA I.V. | inj sic 5x50mg | SAG | D |
| 299 | L01BC | antimetabolity ze skupiny analog pyrimidinu | p.o. |
|---|
| 299.1 | L01BC | azaribin | p.o. | 1 | MG | 8,50 | L/ONK,HEM |
| 299.2 | L01BC02 | fluorouracil | p.o. | 10 | MG | 1,47 | L/ONK,HEM |
| 299.3 | L01BC03 | tegafur | p.o. | 10 | MG | 1,48 | L/ONK,HEM |
| 10407 | FTORAFUR | cps 100x400mg | GRX | LV |
| 299.4 | L01BC06 | capecitabin do 150 mg v jedné tabletě včetně | p.o. | 1 | DF | 35,58 | X |
| 30397 | XELODA 150 MG | por tblflm 60x150mg | HLR | D |
| 299.5 | L01BC06 | capecitabin nad 150 mg v jedné tabletě | p.o. | 1 | DF | 117,97 | X |
| 30402 | XELODA 500 MG | portblflm 120x500mg | HLR | D |
| 300 | L01BC | antimetabolity ze skupiny analog pyrimidinu | parent. |
|---|
| 300.1 | L01BC01 | cytarabin (do 100 mg v jedné ampuli včetně) | parent. | 1 | MG | 1,27 | B/ONK,HEM |
| 99483 | ALEXAN (LAHVICKY) | inj 10x5ml/100mg | MAC | D |
| 99484 | ALEXAN (LAHVICKY) | inj 30x2ml/40mg | MAC | D |
| 08796 | CYTOSAR 100MG | inj sic 1x100mg+5ml | UPJ | B |
| 300.2 | L01BC01 | cytarabin (nad 100 mg v jedné ampuli) | parent. | 1 | MG | 1,03 | B/ONK,HEM |
| 65423 | CYTOSAR 1GM | inj sic 1x1000mg | UPJ | B |
| 96990 | ALEXAN (LAHVICKY) | inj 1x20ml/1000mg | MAC | D |
| 85837 | CYTOSAR 500MG | inj sic 500mg+10ml | UPJ | B |
| 300.3 | L01BC02 | fluorouracil | parent. | 10 | MG | 2,66 | B/ONK,HEM |
| 32753 | FLUORO-URACIL ICN | injsol 1x100ml/5gm | SOC | CH |
| 56055 | 5-FLUOROURACIL EBEWE | inj 1x5ml/250mg | EBP | A |
| 11175 | FLUOROURACIL-TEVA | inj 1x20ml/1000mg | PHM | NL |
| 32752 | FLUORO-URACIL ICN | injsol 5x20ml/1gm | SOC | CH |
| 11173 | FLUOROURACIL-TEVA | inj 1x10ml/500mg | PHM | NL |
| 11394 | LA-FU 50 MG/ML | inj 10x10ml/500mg | PVL | CZ |
| 11117 | LA-FU 50 MG/ML | inj 1x20ml/1000mg | PVL | CZ |
| 32750 | FLUORO-URACIL ICN | injsol 10x5ml/250mg | SOC | CH |
| 11171 | FLUOROURACIL-TEVA | inj 1x5ml/250mg | PHM | NL |
| 32761 | FLUOROURACIL-TEVA | inj sol 1x100ml/5gm | PHM | NL |
| 11393 | LA-FU 50 MG/ML | inj 1x10ml/500mg | PVL | CZ |
| 32751 | FLUORO-URACIL ICN | injsol 5x10ml/500mg | SOC | CH |
| 11100 | LA-FU 50 MG/ML | inj 10x5ml/250mg | PVL | CZ |
| 58240 | FLUORO-URACIL ICN | inj sol 5x5ml/250mg | SOC | CH |
| 57650 | LA-FU 500 | inj 1x10ml/500mg | LCM | CZ |
| 11101 | LA-FU 50 MG/ML | inj 5x20ml/1000mg | PVL | CZ |
| 12665 | 5-FLUOROURACIL EBEWE | inj 1x10ml/500mg | EBP | A |
| 12667 | 5-FLUOROURACIL EBEWE | inj 1x100ml/5000mg | EBP | A |
| 12666 | 5-FLUOROURACIL EBEWE | inj 1x20ml/1000mg | EBP | A |
| 300.4 | L01BC03 | tegafur | parent. | 10 | MG | 2,83 | B/ONK,HEM |
| 300.5 | L01BC05 | gemcitabin | parent. | 1 | MG | 5,87 | X |
| 301 | L01CA | vinka alkaloidy a jejich deriváty | parent. |
|---|
| 301.1 | L01CA01 | vinblastin | parent. | 1 | MG | 26,54 | B/ONK,HEM |
| 301.2 | L01CA02 | vinkristin | parent. | 1 | MG | 165,00 | B/ONK,HEM |
| 11421 | VINCRISTINE-TEVA | inj 1x2ml/2mg | PHM | NL |
| 11422 | VINCRISTINE-TEVA | inj 1x5ml/5mg | PHM | NL |
| 11420 | VINCRISTINE-TEVA | inj 1x1ml/1mg | PHM | NL |
| 301.3 | L01CA04 | vinorelbin | parent. | 1 | MG | 108,27 | X |
| 98203 | NAVELBINE | inj 10x5ml/50mg | PFB | F |
| 301.4 | L01CA04 | vinorelbin | p.o. | 1 | MG | 114,06 | X |
| 05925 | NAVELBINE ORAL 30 MG | por cps mol 1x30mg | PFD | F |
| 05927 | NAVELBINE ORAL 80 MG | por cps mol 1x80mg | PFD | F |
| 05926 | NAVELBINE ORAL 40 MG | por cps mol 1x40mg | PFD | F |
| 05924 | NAVELBINE ORAL 20 MG | por cps mol 1x20mg | PFD | F |
| 302 | L01CB | podofylotoxinové deriváty | p.o. |
|---|
| 302.1 | l01cb01 | etoposid | p.o. | 1 | MG | 3,05 | L/ONK,HEM |
| 97401 | VEPESID | cps 20x50mg | BMS | I | |
| 86710 | VEPESID | cps 10x100mg | BMS | I | |
| 93697 | LASTET | cps 20x50mg | NKU | J | |
| 93696 | LASTET | cps 40x25mg | NKU | J | |
| 93698 | LASTET | cps 10x100mg | NKU | J |
| 303 | L01CB | podofylotoxinové deriváty | parent. |
|---|
| 303.1 | L01CB01 | etoposid | parent. | 1 | MG | 3,02 | B/ONK,HEM |
| 11390 | ETOPOSIDE-TEVA | inf cnc1x10ml/200mg | PHM | NL |
| 11389 | ETOPOSIDE-TEVA | inf cnc 1x5ml/100mg | PHM | NL |
| 86709 | VEPESID | inf cnc10x5ml/100mg | BMS | I |
| 303.2 | L01CB02 | teniposid | parent. | 1 | MG | 6,06 | B/ONK,HEM |
| 304 | L01CD | taxany | parent. |
|---|
| 304.1 | L01CD01 | paclitaxel | parent. | 1 | MG | 140,25 | X |
| 45155 | PAXENE | inf cnc 25ml/150mg | IVX | CZ |
| 05952 | PAXENE | inf cnc16.7ml/100mg | IVX | CZ |
| 05953 | PAXENE | inf cnc 50ml/300mg | IVX | CZ |
| 45154 | PAXENE | inf cnc 1x5ml/30mg | IVX | CZ |
| 304.2 | L01CD02 | docetaxel | parent. | 1 | MG | 245,83 | X |
| 305 | L01DA | aktinomyciny | parent. |
|---|
| 305.1 | L01DA01 | daktinomycin | parent. | 1 | MG | 664,85 | B/ONK,HEM |
| 306 | L01DB | antracykliny a jejich deriváty | p.o. |
|---|
| 306.1 | L01DB06 | idarubicin | p.o. | 1 | MG | 274.70 | X |
| 78814 | ZAVEDOS 25MG | cps 1x25mg | FAR | I |
| 78813 | ZAVEDOS 10MG | cps 1x10mg | FAR | I |
| 78812 | ZAVEDOS 5MG | cps 1x5mg | FAR | I |
| 307 | L01DB | antracykliny a jejich deriváty | parent. |
|---|
| 307.1 | L01DB01 | doxorubicin (do 40 mg včetně v jedné ampuli) | parent. | 1 | MG | 33,58 | B/ONK,HEM |
| 30949 | DOXORUBICIN LACHEMA 10 | inj plv sol 1x10mg | PVL | CZ |
| 12663 | DOXORUBICIN EBEWE 10MG | inj 1x5ml/10mg | EBW | A |
| 307.2 | L01DB01 | doxorubicin (nad 40 mg v jedné ampuli) | parent. | 1 | MG | 32,18 | B/ONK,HEM |
| 30950 | DOXORUBICIN LACHEMA 50 | inj plv sol 1x50mg | PVL | CZ |
| 12664 | DOXORUBICIN EBEWE 50MG | inj 1x25ml/50mg | EBW | A |
| 307.3 | L01DB02 | daunorubicin | parent. | 1 | MG | 19.21 | B/ONK,HEM |
| 307.4 | L01DB03 | epirubicin | parent. | 1 | MG | 35.85 | B/ONK,HEM |
| 58289 | FARMORUBICIN PFS | inj 1x25ml/50mg | PUH | I |
| 307.5 | L01DB04 | aklarubicin | parent. | 1 | MG | 19.21 | B/ONK,HEM |
| 307.6 | L01DB05 | zorubicin | parent. | 1 | MG | 19,21 | B/ONK,HEM |
| 307.7 | L01DB06 | idarubicin | parent. | 1 | MG | 753,57 | B/ONK,HEM |
| 307.8 | L01DB07 | mitoxantron | parent. | 1 | MG | 53,96 | B/ONK,HEM |
| 54033 | REFADOR | inj cnc 1x15ml/30mg | PVL | CZ |
| 308 | L01DC | ostatní cytotoxická antibiotika | parent. |
|---|
| 308.1 | L01DC01 | bleomycin | parent. | 1 | MG | 66,36 | B/ONK,HEM |
| 03404 | BLEOCIN | inj 1x15mg | NKU | J |
| 308.2 | L01DC03 | mitomycin (do 2 mg v jedné ampuli včetně) | parent. | 1 | MG | 76,25 | B/ONK,HEM |
| 308.3 | L01DC03 | mitomycin (nad 2 mg v jedné ampuli) | parent. | 1 | MG | 70,36 | B/ONK,HEM |
| 309 | L01XA | platinová cytostatika | parent. |
|---|
| 309.1 | L01XA01 | cisplatina | parent. | 1 | MG | 8,21 | B/ONK,HEM |
| 96454 | PLATIDIAM | inj 5x25mg/50ml | LCM | CZ |
| 92302 | CISPLATIN EBEWE | inf 1x100ml/50mg | EBW | A |
| 96453 | PLATIDIAM | inj 10x10mg/20ml | LCM | CZ |
| 96455 | PLATIDIAM | inj 1x50mg/100ml | LCM | CZ |
| 309.2 | L01XA02 | karboplatina (do 50 mg v jedné ampuli včetně) | parent. | 1 | MG | 6,70 | B/ONK,HEM |
| 75010 | CYCLOPLATIN 50 | inf cnc sol 1x5ml | PVL | CZ |
| 90777 | CYCLOPLATIN 50 | inf plv sol 10x50mg | PVL | CZ |
| 309.3 | L01XA02 | karboplatina (nad 50 mg v jedné ampuli) | parent. | 1 | MG | 3,86 | B/ONK,HEM |
| 10830 | CARBOPLATIN-TEVA | inj 1x45ml/450mg | PHM | NL |
| 93665 | CYCLOPLATIN 200 | inf plv sol 5x200mg | PVL | CZ |
| 310 | L01XB | methylhydrazinová cytostatika | p.o. |
|---|
| 310.1 | L01XB01 | prokarbazin | p.o. | 10 | MG | 2.44 | L/ONK,HEM |
| 311 | L01XX | ostatní cytostatika | p.o. |
|---|
| 311.1 | L01XX05 | hydroxymočovina | p.o. | 0.1 | GM | 2,23 | L/ONK,HEM, URN |
| 311.2 | L01XX11 | estramustin | p.o. | 10 | MG | 3,91 | L/ONK,HEM, URN |
| 58742 | ESTRACYT | cps 100x140mg | PUA | I |
| 08921 | ESTRACYT | cps 100x140mg | PHA | S |
| 311.3 | L01XX14 | tretinoin | p.o. | 10 | MG | 101,68 | L/ONK,HEM, URN |
| 84009 | VESANOID | cps 100x10mg | HLR | CH |
| 311.4 | L01XX28 | imatinib | p.o. | 400 | MG | 2672,95 | X |
| 40199 | GLIVEC 100MG | cps 120x100mg | NPF | CH |
| 312 | L01XX | ostatní cytostatika | parent. |
|---|
| 312.1 | L01XC04 | alemtuzumab | parent. | 1 | MG | 442.20 | X |
| 312.2 | L01XC02 | rituximab | parent. | 10 | MG | 1234,71 | X |
| 59839 | MABTHERA 100MG | inf 2x10ml/100mg | HLR | D |
| 46130 | MABTHERA 500MG | inf 1x50ml/500mg | HLR | D |
| 312.3 | L01XC03 | trastuzumab | parent. | 1 | DF | 25.414,00 | X |
| 312.4 | L01XD02 | verteporfin | parent. | 15 | MG | 44000.00 | X |
| 312.5 | L01XX01 | amsakrin | parent. | 1 | MG | 25,80 | B/ONK,HEM |
| 312.6 | L01XX02 | asparagináza | parent. | 1 | MG | 2784,54 | B/ONK,HEM |
| 58319 | KIDROLASE | inj sic 10x10ku | THN | B |
| 94058 | ERWINASE | inj sic 20x10ku | POT | GB |
| 312.7 | L01XX11 | estramustin | parent. | 1 | MG | 1,03 | B/ONK,HEM, UR N |
| 312.8 | L01XX17 | topotekan | parent. | 1 | MG | 3066,38 | X |
| 312.9 | L01XX19 | irinotekan | parent. | 1 | MG | 72,40 | X |
| 312.10 | L01XX09 | miltefosin | lok. | 60 | MG | 9,78 | |
| 313 | L02AA | estrogeny | p.o. |
|---|
| 313.1 | L02AA01 | diethylstilbestrol | p.o. | 10 | MG | 3,32 | L/ONK,HEM, URN GYN,SEX |
| 313.2 | L02AA03 | ethinylestradiol | p.o. | 1 | MG | 4,06 | L/ONK,HEM, URN GYN,SEX |
| 313.3 | L02AA04 | fosfestrol | p.o. | 0.1 | GM | 3,32 | L/ONK,HEM, URN GYN,SEX |
| 314 | L02AA | estrogeny | parent. |
|---|
| 314.1 | L02AA01 | diethylstilbestrol | parent. | 10 | MG | 6,55 | B/ONK,HEM, URN,SEX |
| 314.2 | L02AA02 | polyestradiol fosfát | parent. | 1 | MG | 3,18 | B/ONK,HEM, URN,SEX |
| 314.3 | L02AA04 | fosfestrol | parent. | 0.1 | GM | 4,79 | B/ONK,HEM, URN,SEX |
| 315 | L02AB | progestiny | p.o. |
|---|
| 315.1 | L02AB01 | megestrol (pevné lékové formy) | p.o. | 160 | MG | 39,89 | L/ONK,HEM, URN GYN,SEX |
| 315.2 | L02AB01 | megestrol (tekuté lékové formy) | p.o. | 160 | MG | 70,97 | P |